Up to 7% of PD patients carry a mutation in the GBA1 gene [113], whereas PD patients that do not carry a GBA1 mutation also show a significant reduction in lysosomal GCase activity [114,115]. This evidence concerns the gene GBA1 and Parkinson disease.